GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Omnicell Inc (STU:OC9) » Definitions » Cyclically Adjusted Revenue per Share

Omnicell (STU:OC9) Cyclically Adjusted Revenue per Share : €21.98 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Omnicell Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Omnicell's adjusted revenue per share for the three months ended in Mar. 2024 was €4.952. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €21.98 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Omnicell's average Cyclically Adjusted Revenue Growth Rate was 8.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 13.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 13.00% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 12.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Omnicell was 13.90% per year. The lowest was 9.10% per year. And the median was 12.40% per year.

As of today (2024-06-03), Omnicell's current stock price is €29.80. Omnicell's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €21.98. Omnicell's Cyclically Adjusted PS Ratio of today is 1.36.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Omnicell was 10.20. The lowest was 1.13. And the median was 4.00.


Omnicell Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Omnicell's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnicell Cyclically Adjusted Revenue per Share Chart

Omnicell Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.09 12.54 16.44 19.54 21.74

Omnicell Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.49 20.54 22.10 21.74 21.98

Competitive Comparison of Omnicell's Cyclically Adjusted Revenue per Share

For the Health Information Services subindustry, Omnicell's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omnicell's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Omnicell's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Omnicell's Cyclically Adjusted PS Ratio falls into.



Omnicell Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Omnicell's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4.952/131.7762*131.7762
=4.952

Current CPI (Mar. 2024) = 131.7762.

Omnicell Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 2.111 100.560 2.766
201409 2.371 100.428 3.111
201412 2.690 99.070 3.578
201503 2.909 99.621 3.848
201506 2.714 100.684 3.552
201509 3.048 100.392 4.001
201512 3.299 99.792 4.356
201603 4.297 100.470 5.636
201606 4.276 101.688 5.541
201609 4.247 101.861 5.494
201612 4.446 101.863 5.752
201703 3.770 102.862 4.830
201706 4.199 103.349 5.354
201709 4.020 104.136 5.087
201712 3.854 104.011 4.883
201803 3.731 105.290 4.670
201806 4.038 106.317 5.005
201809 4.284 106.507 5.300
201812 4.482 105.998 5.572
201903 4.239 107.251 5.208
201906 4.480 108.070 5.463
201909 4.826 108.329 5.871
201912 5.151 108.420 6.261
202003 4.765 108.902 5.766
202006 4.155 108.767 5.034
202009 4.153 109.815 4.984
202012 4.654 109.897 5.581
202103 4.562 111.754 5.379
202106 4.806 114.631 5.525
202109 5.212 115.734 5.934
202112 5.485 117.630 6.145
202203 6.041 121.301 6.563
202206 6.777 125.017 7.143
202209 7.672 125.227 8.073
202212 6.289 125.222 6.618
202303 6.047 127.348 6.257
202306 6.069 128.729 6.213
202309 6.138 129.860 6.229
202312 5.217 129.419 5.312
202403 4.952 131.776 4.952

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Omnicell  (STU:OC9) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Omnicell's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=29.80/21.98
=1.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Omnicell was 10.20. The lowest was 1.13. And the median was 4.00.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Omnicell Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Omnicell's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Omnicell (STU:OC9) Business Description

Industry
Traded in Other Exchanges
Address
2625 Augustine Drive, Suite 301, Santa Clara, CA, USA, 95054
Omnicell Inc provides automation and business analytics software for healthcare providers. The automation and analytics segment manufactures medication dispensing systems, pharmacy inventory management systems, and related software. The medication adherence segment sells products like consumable medication blister cards and packaging equipment to help administer medication outside of a hospital setting. Omnicell generates the vast majority of its revenue in the United States.

Omnicell (STU:OC9) Headlines

No Headlines